Characterization of a low molecular mass form of insulin-like growth factor binding protein-3 (17.7 kilodaltons) in urine and serum from healthy children and growth hormone (GH)-deficient patients: relationship with GH therapy.
Anna Spagnoli(Rush University Medical Center), R G Rosenfeld(Laboratório Interinstitucional de e-Astronomia), Youngman Oh(Virginia Commonwealth University), Sharron Gargosky(Stanford University), Gian Luigi Spadoni(University of Rome Tor Vergata), Margaret MacGillivray(Stanford University), B Boscherini(University of Rome Tor Vergata)
Cited by 19
Related Papers
Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition
|Journal of Biological Chemistry|1993|477
Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth.
|The Journal of Clinical Endocrinology & Metabolism|1995|365
Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease
|Journal of Endocrinology|1994|271
Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
|The Journal of Clinical Endocrinology & Metabolism|1993|203
Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth.
|Molecular Endocrinology|1993|160